T2 Biosystems (TTOO) 2014年年度报告「NASDAQ」.pdf

《T2 Biosystems (TTOO) 2014年年度报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《T2 Biosystems (TTOO) 2014年年度报告「NASDAQ」.pdf（135页珍藏版）》请在三个皮匠报告上搜索。

1、 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-K (Mark One)xx ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31,2014 oo TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 19

2、34 For the transition period from to Commission File Number:001-36571 T2 Biosystems,Inc.(Exact name of registrant as specified in its charter)Delaware20-4827488(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)101 Hartwell Avenue,Lexington,MA02421(Addre

3、ss of principal executive offices)(Zip code)Registrants telephone number,including area code:781-457-1200 Securities registered pursuant to Section 12(b)of the Act Title of Each Class:Name of Each Exchange on which Registered:Common Stock,par value$0.001 per shareThe NASDAQ Stock Market LLC(NASDAQ G

4、lobal Market)Securities registered pursuant to Section 12(g)of the Act:None Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act of 1933,as amended.YES o NO x Indicate by check mark if the registrant is not required to file reports pur

5、suant to Section 13 or Section 15(d)of the Securities Exchange Act of 1934,as amended.YES o NO x Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12months(or for such shorter p

6、eriod that the registrant was required to file such reports)and(2)has been subject to such filing requirements for the past 90 days.Yes x No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site,if any,every Interactive Data File required t